Literature DB >> 16487234

Hydroxylation of lansoprazole in poor metabolizers of CYP2C19.

Takahisa Furuta, Naohito Shirai, Mitsushige Sugimoto, Akiko Nakamura, Akira Hishida.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16487234      PMCID： PMC1885018          DOI： 10.1111/j.1365-2125.2005.02551.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  2 in total

1.  Effects of clarithromycin on the metabolism of omeprazole in relation to CYP2C19 genotype status in humans.

Authors:  T Furuta; K Ohashi; K Kobayashi; I Iida; H Yoshida; N Shirai; M Takashima; K Kosuge; H Hanai; K Chiba; T Ishizaki; E Kaneko
Journal:  Clin Pharmacol Ther       Date:  1999-09       Impact factor: 6.875

2.  Effects of clarithromycin on lansoprazole pharmacokinetics between CYP2C19 genotypes.

Authors:  Masato Saito; Norio Yasui-Furukori; Tsukasa Uno; Takenori Takahata; Kazunobu Sugawara; Akihiro Munakata; Tomonori Tateishi
Journal:  Br J Clin Pharmacol       Date:  2005-03       Impact factor: 4.335
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.